Increasing skeletal muscle carnitine availability does not alter the adaptations to high-intensity interval training by Shannon, CE et al.
Increasing skeletal muscle carnitine availability does not alter the adaptations to high-
intensity exercise training 
Christopher E. Shannon1,3, Reza Ghasemi1, Paul L. Greenhaff1 and Francis B Stephens1,2  
 
1MRC/ARUK Centre for Musculoskeletal Ageing Research, School of Life Sciences, 
University of Nottingham, UK. 
2School of Sport and Health Sciences, St Luke's Campus, University of Exeter, Exeter, UK 
3Diabetes Division, University of Texas Health Science Centre, 7703 Floyd Curl Dr, San 
Antonio, TX 78229, USA 
 
To whom correspondence should be addressed: Dr Francis Stephens  
Richard's Building, University of Exeter, St Luke's Campus, Heavitree Road, Exeter, EX1 
2LU, UK. Tel: +44 (0) 1392 722157 Email: F.B.Stephens@exeter.ac.uk 
 
Running head: Muscle carnitine loading and high intensity training 
 
 
 
 
 
 
 
 
 
 
Abstract 
Increasing skeletal muscle carnitine availability alters muscle metabolism during steady-state 
exercise in healthy humans. 	We investigated whether elevating muscle carnitine, and thereby 
the acetyl-group buffering capacity, altered the metabolic and physiological adaptations to 24 
weeks of high-intensity training (HIT) at 100% maximal exercise capacity (Wattmax). 
Twenty-one healthy male volunteers (age 23±2 years; BMI 24.2±1.1 kg/m2) performed 2x3 
minute bouts of cycling exercise at 100% Wattmax, separated by five minutes rest. Fourteen 
volunteers repeated this protocol following 24 weeks of HIT and twice-daily consumption of 
80g carbohydrate (CON) or 3g L-carnitine+carbohydrate (CARN). Before HIT, muscle 
phosphocreatine (PCr) degradation (P<0.0001), glycogenolysis(P<0.0005), PDC activation 
(P<0.05), and acetylcarnitine(P<0.005) were 2.3, 2.1, 1.5 and 1.5-fold greater, respectively, 
in exercise bout two compared to bout one, whilst lactate accumulation tended (P<0.07) to be 
1.5-fold greater. Following HIT, muscle free carnitine was 30% greater in CARN vs CON at 
rest and remained 40% elevated prior to the start of bout two (P<0.05). Following bout two, 
free carnitine was no different, and PCr degradation, glycogenolysis, lactate accumulation, 
and PDC activation were all similar between CON and CARN, albeit markedly lower than 
before HIT. VO2max, Wattmax and work-output were similarly increased in CON and CARN, 
by 9, 15 and 23% (P<0.001), respectively. In summary, increased reliance on non-
mitochondrial ATP resynthesis during a second bout of intense exercise is accompanied by 
increased carnitine acetylation. Augmenting muscle carnitine availability during 24 weeks of 
HIT did not alter this, nor enhance muscle metabolic adaptations or performance gains 
beyond those with HIT alone. 
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Introduction 
The reversible esterification of skeletal muscle free carnitine with acetyl-CoA, by the 
mitochondrial enzyme carnitine acetyltransferase (CAT), maintains a viable pool of free 
coenzyme A and thereby facilitates pyruvate dehydrogenase complex (PDC) and TCA cycle 
fluxes under conditions of elevated ATP demand (Childress & Sacktor, 1966; Constantin-
Teodosiu et al., 1991a). This is evidenced by the linear relationship that exists between 
acetyl-CoA and acetylcarnitine accumulation across sub-maximal exercise intensities (Carlin 
et al., 1990; Constantin-Teodosiu et al., 1991a), as well as the finding that increasing skeletal 
muscle free carnitine availability in healthy humans resulted in a greater acetylcarnitine 
accumulation and PDC activation during exercise at 80% maximal aerobic capacity (VO2max), 
which was concomitant with a lower rate of phosphocreatine (PCr) degradation and a 
diversion of glycogenolysis away from lactate accumulation (Wall et al., 2011). However, 
during very intense exercise there is a plateau in muscle acetyl-group concentration that is 
associated with a greatly accelerated rate of lactate formation (Harris & Foster, 1990; 
Stephens et al., 2007a) and yet it is not clear whether the availability of free carnitine is 
limiting to PDC flux and mitochondrial ATP resynthesis, or simply that TCA cycle flux and 
PDC flux are maximal and well matched. In support of the latter it was previously 
demonstrated that during five minutes of leg extension exercise at 100% maximal workload 
(Wattmax), in-vitro determination of PDC activation accounted for 90% of the estimated TCA 
cycle flux from leg O2 uptake (Gibala et al., 1998). Moreover, using the same model Bangsbo 
and colleagues (2001) reported that mitochondrial ATP delivery was enhanced in a second 
three minute bout of single leg-extension at 100% Wattmax, when free carnitine availability 
would presumably have been reduced (Putman et al., 1995). However, the limitations to 
mitochondrial ATP delivery during single leg exercise are not entirely analogous with two-
legged cycling (Andersen & Saltin, 1985; Boushel et al., 2011) and skeletal muscle carnitine 
metabolism was not determined in these studies.  
 
Exercise training robustly enhances the capacity for mitochondrial ATP resynthesis and is 
paralleled by reciprocal reductions in the reliance on PCr degradation and glycolytic ATP 
delivery (Vollaard et al., 2009). These metabolic adaptations reflect a better matching of 
glycolysis, PDC and TCA cycle fluxes and underpin the functional improvements observed 
in power output and endurance performance following classical endurance exercise (Holloszy 
et al., 1977). Low volume, high-intensity interval exercise (HIT) is much promoted as a time-
efficient strategy to stimulate metabolic and functional adaptations comparable to continuous 
endurance-type exercise (Burgomaster et al., 2008) and is well tolerated when practical 
workloads (i.e. ~100% VO2max) are employed (Little et al., 2010). This type of exercise 
paradigm markedly increases glycolytic and mitochondrial ATP demand but the acetyl-group 
buffering role of carnitine under these conditions has not been investigated.  If carnitine 
availability is indeed limiting to PDC flux during intense, repeated-bout exercise, it is 
plausible that increasing skeletal muscle carnitine availability as in (Wall et al., 2011) during 
a prolonged period of HIT could influence the adaptations to this type of training. The current 
study was conducted to gain further insight into the role of skeletal muscle acetyl-group 
buffering, PDC flux and mitochondrial ATP production during two consecutive bouts of 
fixed-workload cycling exercise at Wattmax. Moreover, it was subsequently investigated 
whether increasing muscle carnitine could lower the reliance on non-mitochondrial ATP 
production, particularly during a second bout of intense exercise and consequently improve 
training-induced gains in exercise capacity (VO2max, Wattmax) and performance (work output). 
 
 
Materials and Methods 
Volunteers 
Twenty-one healthy, non-vegetarian, untrained males (age 23 ± 2 years; BMI 24.2 ± 1.1 
kg/m2; VO2max 45 ± 3 ml/kg/min) gave written informed consent and attended a routine 
medical screening prior to participating in the present study which was approved by the 
University of Nottingham Medical School Ethics Committee.  
Protocol 
Baseline testing: The overall study protocol is depicted in Figure 1A. All volunteers 
completed a continuous, incremental exercise test to volitional exhaustion on an 
electronically-braked cycle ergometer (Lode Excalibur; Lode, Groningen, The Netherlands) 
to determine their VO2max (SensorMedics, USA) and the constant workload that would elicit 
this (Wattmax). Both parameters were confirmed on a separate occasion and volunteers were 
subsequently familiarised with the experimental protocol one week prior to the experimental 
visit. On the day of the main experimental visit, volunteers arrived at the laboratory (~8.30 
am) following an overnight fast and having abstained from alcohol, caffeine or strenuous 
exercise for 48 hours. Following a 30 minute period of supine rest, a single muscle biopsy 
was obtained (Bergstrom, 1975) and volunteers completed a three minute warm-up period on 
the cycle ergometer at an intensity (25% Wattmax) known to have a negligible impact upon 
muscle acetyl-group concentrations (Constantin-Teodosiu et al., 1991a; Howlett et al., 1998). 
Volunteers subsequently cycled for three minutes at their pre-determined Wattmax workload 
and, upon cessation of exercise, a second biopsy was immediately obtained from the same leg 
as the first. Volunteers then rested for five minutes before completing a second three minute 
bout of exercise at the same absolute workload, with further biopsies obtained from the 
contralateral leg immediately before and after the second bout (Figure 1B).  
Following the initial baseline experimental visit, fourteen volunteers were randomised to 
receive either L-carnitine (n=7) or placebo (n=7) supplementation during a 24 week period of 
supervised HIT (see below), with the absolute training workload adjusted to reflect any 
changes in Wattmax which, along with VO2max, was reassessed after 4, 8, 12, 18 and 24 weeks. 
The main experimental study visit was then repeated at 24 weeks and an additional resting 
muscle biopsy was obtained at 12 weeks.  
High-intensity training: Volunteers trained three times per week (normally Monday, 
Wednesday and Friday) and were required to complete >85% of all training sessions over 24 
weeks for inclusion in the final data set. All training sessions involved a three minute warm-
up at 25% Wattmax followed by 3 x 3 minute exercise bouts at Wattmax and a fourth bout to 
exhaustion, each separated by five minute passive recovery periods. During the fourth bout of 
each training session, volunteers received standardised verbal encouragement to exercise as 
long as they could (typically less than six minutes). The absolute training workload was 
adjusted, in line with the reassessment of Wattmax every four weeks (Figure 1A), to maintain 
a constant relative intensity of Wattmax. Additionally, when volunteers were able to exercise 
for six minutes in the final bout during more than two consecutive training sessions, the 
workload was increased by a further 1% for the subsequent training session. This approach 
maximised total work output, whilst restricting exercise duration to 15 minutes, in every 
training session. 
Supplementation: Volunteers were assigned to receive twice-daily beverages of either 80 g 
carbohydrate (Maldex 180, SYRAL Belgium; CON) or 80 g carbohydrate plus 2.25 g L-
carnitine tartrate (1.5 g L-carnitine; Nutramet, UK; CARN) in a randomised, double-blinded 
fashion. The quantities of L-carnitine and carbohydrate provided were identical to those used 
in a prior study (Wall et al., 2011). Drinks were made up in 500 ml cold water from sachets 
of powder and were matched for flavour, appearance and carbohydrate type. Volunteers were 
instructed to consume one beverage first thing in the morning, and the second beverage four 
hours later to maximise the time period over which plasma carnitine and serum insulin 
concentrations were simultaneously elevated (Stephens et al., 2007b; Shannon et al., 2016). 
Sampling and analysis 
Muscle biopsies were rapidly frozen (~10 seconds) in liquid nitrogen-cooled isopentane and a 
~50 mg (wet weight; [ww]) portion was freeze-dried for the determination of free, acetyl and 
total carnitine (Cederblad et al., 1990), as well as ATP, PCr, lactate and glycogen, corrected 
(excluding lactate) for muscle total creatine (Harris et al., 1974). A second portion (~15 mg 
ww) was used for the determination of PDC activation status (Constantin-Teodosiu et al., 
1991b). Total carnitine was also determined in the 12 week muscle biopsy and in plasma 
samples.  
Calculations and statistical analysis 
Wattmax was calculated as W’+(30·T/180) where W’ (watts [joules/sec]) is the highest 
workload completed and T (secs) is the time attained in the final (incomplete) stage at 
exhaustion during the incremental exercise test. The theoretical rate of non-mitochondrial 
ATP resynthesis, attributed to ATP breakdown, PCr degradation and lactate accumulation 
(Constantin-Teodosiu et al., 2009), was estimated from the equation: Δ[PCr]+ 
1.5·∆[lactate]+2·∆[ATP]. In non-occluded muscle, this equation ignores lactate efflux and 
intermediary metabolite concentrations, but still provides a relative index reflective of the 
overall matching of oxidative ATP production to total ATP demand. Glycogenolysis was 
calculated as Δ[glycogen]. Baseline metabolite concentrations and delta values were 
compared using two-way ANOVA (exercise x bout) or paired t-test, respectively. Post-
training data were compared separately using two-way ANOVA (exercise x 
supplementation), with Bonferoni-corrected t-test post-hoc. All data are presented as mean ± 
SE, with absolute metabolite concentrations expressed in mmol·kg dry weight (dw)-1.  
Results 
Baseline repeated-bout exercise metabolism 
Skeletal muscle carnitine metabolism and PDCa 
Muscle free carnitine concentration declined by 28% (P<0.05) during bout one and remained 
unchanged during recovery, before declining a further 39% (P<0.01) during bout two (Figure 
2A). Acetylcarnitine concentrations mirrored the decline in free carnitine, increasing by 2.3-
fold and 1.7-fold during bout one and bout two, respectively (both P<0.05; Figure 2A), 
whilst absolute acetylcarnitine accumulation (Δ[acetylcarnitine]) was similar between bout 
one and two (4.1 ± 0.9 and 4.2 ± 0.9 mmol·kg dw-1, respectively). PDCa increased 2.1-fold 
(P<0.01) during bout one before returning to basal values prior to the start of bout two. 
During bout two, PDCa increased 3.3-fold (P<0.001), to a greater extent than during bout one 
(interaction effect P<0.05; Figure 2B). 
Non-mitochondrial ATP delivery and glycogenolysis 
ATP concentration declined progressively during bout one (from 26.1 ± 0.7 to 23.5 ± 0.8; 
P<0.05) and bout two (from 24.0 ± 1.0 to 20.7 ± 0.9 mmol·kg dw-1; P<0.01) with a similar 
Δ[ATP] in each bout (P=0.5; Figure 2C, black bars). PCr concentration declined during bout 
one from 76.5 ± 2.3 to 52.9 ± 4.6 mmol·kg dw-1 (P<0.001) before returning to resting values 
prior to the start of the second bout. During bout two, PCr concentration fell to 23.4 ± 3.4 
mmol·kg dw-1, such that Δ[PCr] was 2.3-fold greater than during bout one (P<0.001; Figure 
2C, white bars). Muscle lactate increased from a resting value of 6.0 ± 0.8 to 49.0 ± 9.8 
mmol·kg dw-1 (P<0.01) during bout one and remained elevated above basal values (P<0.05) 
prior to the start of the second bout (26.6 ± 5.4 mmol·kg dw-1). During bout two, muscle 
lactate increased further to 92.9 ± 7.4 mmol·kg dw-1, with Δ[lactate] tending to be 1.5-fold 
greater during bout two than bout one (P=0.07; Figure 2C, dotted bars). The total calculated 
ATP delivery from non-mitochondrial routes was 1.7-fold greater during bout two versus 
bout one (159.4 ± 12.0 vs. 93.3 ± 19.5 mmol ATP·kg dw-1; P<0.01; Figure 2C, summed 
bars). Resting muscle glycogen concentration was 396 ± 18 mmol·kg dw-1 and declined by 
15% and 32% during bout one and bout two, respectively (both P<0.001), such that 
Δ[glycogen] was 2.1-fold greater during bout two than bout one (P<0.001; Figure 2D).   
Post-supplementation  
Following randomisation, CON and CARN groups were well matched for baseline exercise 
capacity (Figure 3A-C) and skeletal muscle metabolism during repeated-bout exercise 
(supporting Table 1).  
Exercise capacity and work performance  
Twenty-four weeks of HIT increased VO2max by ~9% (Figure 3A), Wattmax by ~15% (Figure 
3B) and work output during training by ~23% (Figure 3C) in CON and CARN (all P<0.001), 
with no differences between groups. These adaptations occurred primarily between 0-12 
weeks, with no further improvements observed between 12-24 weeks (Figure 3A-C).  
Relative changes were not influenced by normalising values to body weight.   
Post-supplementation skeletal muscle carnitine metabolism and PDCa 
Skeletal muscle total carnitine in the CON group decreased from baseline to 12 weeks (17.8 ± 
1.0 vs 15.7 ± 1.2; P<0.05) but was no different from baseline by 24 weeks (16.9 ± 1.0; 
P=0.17 vs baseline). In contrast, total carnitine in the CARN group was unchanged from 
baseline at 12 weeks (19.4 ± 129 vs. 19.5 ± 1.9; P=0.9) but tended to increase at 24 weeks 
(20.9 ± 1.8; P=0.06 vs baseline), such that the absolute change from baseline was 
significantly greater in CARN than CON (1.5 ± 0.7 vs -0.9 ± 0.6 mmol·kg dw-1; P<0.05). 
This resulted in a 30% greater resting free carnitine availability in CARN versus CON 
(P<0.05) and, following an initial exercise bout, free carnitine remained 28% greater in 
CARN vs CON (P<0.05; Figure 4A). However, following the second exercise bout, free 
carnitine values were similar between groups (Figure 4A). Post-exercise PDCa was no 
different between CON and CARN for either exercise bout (Figure 4B).  
Post-supplementation non-mitochondrial ATP delivery and glycogenolysis  
ATP, PCr degradation and lactate accumulation following HIT were all similar between CON 
and CARN treated groups in both exercise bouts (Figure 4C). There was a main effect of 
HIT for reducing Δ[PCr] and Δ[lactate] across both groups in bout one (P<0.05) and bout two 
(P<0.01). Resting muscle glycogen increased 1.5- and 1.4-fold in CON (P<0.01) and CARN 
(P<0.05), respectively, following HIT but remained similar between groups. There were no 
differences in Δ[glycogen] between CON and CARN during bout one or bout two (Figure 
4D), although Δ[glycogen] in bout two was lower for both groups following HIT (main effect 
of HIT; P<0.01).  
 
 
 
 
 
 
Discussion 
The principle finding of the present study was that increasing skeletal muscle free carnitine 
content and the capacity to buffer excess acetyl groups during repeated 3 min bouts of high-
intensity exercise at 100% Wattmax did not further influence skeletal muscle metabolism 
during this exercise paradigm, nor improve training-induced changes in muscle metabolism, 
VO2max, Wattmax, or work output over 24 weeks of high-intensity interval training (HIT). This 
would suggest that either acetylcarnitine formation, or PDC flux, is not limiting to 
mitochondrial ATP delivery during repeated bouts of exercise of this duration and intensity, 
or that the adaptations to HIT outweighed any benefit of increasing free carnitine availability. 
Indeed, a novel finding of the present study was that during a repeated bout of intense cycling 
exercise at Wattmax, where free carnitine availability was reduced, the reliance on 
phosphocreatine degradation increased, which is indicative of a declining contribution from 
mitochondrial ATP delivery. However, following 24 weeks of HIT non-mitochondrial ATP 
production and acetylcarnitine accumulation during a second bout of exercise were blunted to 
such an extent that they were lower than the pre-training first bout. Taken together these data 
suggest that 24 weeks of HIT per se results in a better matching of PDC and TCA cycle flux 
during repeated bouts of exercise, lowering the dependence on mitochondrial acetyl-group 
buffering.  
In contrast to previous reports that reliance on non-mitochondrial ATP delivery is lessened 
over repeated bouts of intense exercise (Putman et al., 1995; Bangsbo et al., 2001), here we 
observed a two-fold greater PCr degradation during the second exercise bout relative to the 
first. Resynthesis of PCr, via the mitochondrial creatine kinase shuttle, relies on 
mitochondrial ATP provision (Perry et al., 2012) and thus the extent of PCr degradation 
during exercise can be considered a sensitive marker of mitochondrial ATP delivery. Indeed, 
total non-mitochondrial ATP production, a reciprocal index of oxidative ATP delivery, was 
71% greater during the second exercise bout. Assuming a negligible contribution from fat 
oxidation at this intensity (Venables et al., 2005) and taken together with the continued rise in 
muscle lactate concentrations and the doubling of glycogenolysis, these data strongly contend 
that mitochondrial ATP provision was compromised during the second bout relative to the 
first. The discrepancy between this finding and data from previous studies probably relates to 
methodological differences. For example, Bangsbo and colleagues (2001) assessed rates of 
PCr degradation during two bouts of single-leg knee extension, which allows a greater blood 
flow per unit muscle mass  and likely imposes more modest restrictions on mitochondrial 
ATP delivery (Boushel et al., 2011).  On the other hand, the evaluation of repeated-bout 
exercise metabolism using maximal two-legged cycle sprints precludes complete PCr 
resynthesis between bouts and is further confounded by the inability to maintain a constant 
work output across successive bouts (Putman et al., 1995). With fixed-workload, two-legged 
cycling, we postulated that despite similar or greater PDC activation, the continued decline of 
free carnitine availability during a second exercise bout may restrict acetyl-group delivery to 
the TCA cycle by impairing PDC flux (Wall et al., 2011), which thus provides a rationale for 
attempting to manipulate muscle carnitine content during chronic HIT.  
Using the same L-carnitine supplementation strategy as that employed previously in our lab 
(Wall et al., 2011), here we were able to increase resting skeletal muscle free carnitine 
availability following a period of HIT. Importantly, and in line with previous findings of Wall 
et al., (2011), this post-supplementation elevation of free carnitine persisted throughout, and 
during recovery from, the first exercise bout at 100% Wattmax. The latter was hypothesised to 
prevent the apparent decline in mitochondrial ATP production during a second exercise bout, 
as observed prior to supplementation, by facilitating a greater flux through the PDC.  
However, post-supplementation neither PDC activation, nor carnitine acetylation were 
appreciably different between CON and CARN following bout two, which would suggest 
that PDC flux during the second bout was comparable between groups. Thus, it would appear 
that the increased availability of free carnitine in CARN did not translate into an 
enhancement of mitochondrial acetyl-group delivery or any further sparing of PCr 
degradation or lactate accumulation compared to CON. This is somewhat surprising, 
considering the robust physiological and gene network adaptations previously reported in 
carbohydrate and lipid metabolism following carnitine supplementation (Wall et al., 2011; 
Stephens et al., 2013).  It is possible that the three minute exercise bouts employed in the 
current study were of insufficient duration to allow the plateau in acetyl-group accumulation 
typically observed within 10 minutes of exercise at 75-90% VO2max  (Hiatt et al., 1989; 
Constantin-Teodosiu et al., 1992), such that the maximal capacity of carnitine to buffer 
mitochondrial acetyl-group accumulation becomes less critical. Indeed, carnitine acetylation 
during bout two, following HIT, in the current study reached only ~35% of the free + 
acetylcarnitine pool. This value is approximately half that observed following 20 minutes of 
exercise at 80% VO2max, whereupon increasing skeletal muscle carnitine availability did 
indeed influence anaerobic energy production (Wall et al., 2011). In this respect, the lower 
intensity and greater duration of the exercise protocol employed by Wall and colleagues 
(2011) likely permitted a greater contribution of lipids to acetyl-group delivery than in the 
current study (van Loon et al., 2001), which may augment the dependence of mitochondrial 
ATP production on free carnitine availability. Ultimately, despite substantial reductions in 
lactate accumulation and PCr utilisation compared to baseline, reliance on non-mitochondrial 
ATP delivery was still markedly greater in a second exercise bout relative to the first. 
Increasing free carnitine availability prior to the start of the second bout did not alter this, 
suggesting that factors other than the mitochondrial acetyl-group buffering capacity (e.g. 
electron transport chain oxygen availability (Boushel & Saltin, 2013)) are limiting oxidative 
ATP delivery under these conditions. In view of these data, it seems unlikely that metabolic 
flux was appreciably altered in CARN during training sessions, where four successive 
exercise bouts were performed at Wattmax, particularly as work output was equivalent 
between groups throughout the 24 week HIT period, and it is thus perhaps unsurprising that 
the gains in VO2max and Wattmax were comparable. 
Limited data exist on the plasticity of the muscle carnitine stores in response to exercise 
training. Here we found 12 weeks HIT to be associated with a transient 12% decline in 
skeletal muscle total carnitine content (in CON), before partial restoration after 24 weeks 
continued training.  Importantly, and consistent with one previous report on the impact of L-
carnitine supplementation during training (Arenas et al., 1991), the carnitine loading strategy 
used here was able to avert the observed decline in muscle carnitine content. The reason for 
the initial decline in muscle carnitine in CON is unclear, but given the prospective influence 
of habitual diet on the transcriptional regulation of tissue carnitine content (Stephens et al., 
2011; Zhou et al., 2014a; Zhou et al., 2014b), could be an adaptation to the 160 g/day 
carbohydrate load, which we have previously shown to influence transcription factor (e.g. 
PPARα) expression in skeletal muscle differentially to carbohydrate plus L-carnitine feeding 
(Stephens et al., 2013). Alternatively, the decline in muscle carnitine content could reflect an 
adaptation to the highly glycolytic nature of the training paradigm, during the initial 8-12 
weeks of the intervention when the gains in work output (and presumably metabolic 
adaptations) were greatest. In relation to this, the temporal nature of the adaptations observed 
here raises the question as to whether the widely-reported health benefits of short-term HIT 
(Gillen & Gibala, 2013; Sloth et al., 2013) can continue to improve beyond 12 weeks.   
In conclusion, these data demonstrate that daily L-carnitine and carbohydrate feeding can be 
used to manipulate skeletal muscle free carnitine content during a sustained period of HIT. 
However, elevating muscle free carnitine availability during HIT does not appear to influence 
the training-induced increase in mitochondrial ATP provision across repeated bouts of high-
intensity cycling exercise, suggesting that the skeletal muscle adaptations to HIT are not 
restricted by free carnitine availability or the mitochondrial acetyl-group buffering capacity. 
As a result, the whole-body gains in exercise performance and capacity following HIT were 
not augmented by the manipulation of muscle carnitine content. Nevertheless, the previously 
reported enhancement of exercise metabolism by skeletal muscle carnitine loading (Wall et 
al., 2011) may still be of benefit to training paradigms that employ steady-state exercise 
intensities lower than 100% Wattmax.  
 
Perspectives 
Augmenting skeletal muscle carnitine content can demonstrably alter steady-state exercise 
metabolism, body adiposity and the expression of related gene-networks (Wall et al., 2011; 
Stephens et al., 2013). More recent observational concepts on the acetyl-group buffering role 
of carnitine in human metabolism and health (Davies et al., 2016) lack longitudinal support. 
Here we increased free carnitine availability during a 24 week period of high-intensity 
exercise training and show that the skeletal muscle acetyl-group buffering capacity is unlikely 
limiting to the metabolic and physiological adaptations to this type of training paradigm.   
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Figure legends 
Figure 1 Schematic outlining study visit protocols A: At baseline, volunteers completed an 
exercise study visit (see B) and, following randomisation into either CON (n=7) or CARN 
(n=7), completed 24 weeks of HIT and supplementation before a second exercise study visit. 
B: For exercise study visits, volunteers performed two 3 minute bouts of cycle ergometer 
exercise at 100% of their predetermined Wattmax, separated by a five minute passive recovery 
period. Muscle biopsies (arrows) were obtained before and after each exercise bout. A three 
minute warm-up period at 25% Wattmax was completed prior to the first exercise bout 
(following the resting muscle biopsy). *The first three exercise bouts lasted three minutes, the 
fourth bout was open-ended to allow exercise until exhaustion but generally lasted 0- 
minutes. Dotted arrow indicates that only a resting biopsy was taken.  
 
Figure 2 Repeated-bout exercise metabolism Free carnitine (black bars) and acetylcarnitine 
(dotted grey bars) concentration (A) and PDC activation status (B) before and after two 3 
minute cycle ergometer exercise bouts at 100% Wattmax separated by five mintues passive 
recovery. The contribution of ATP degradation (black bars), PCr degradation (white bars) 
and lactate accumulation (dotted bars) to total non-mitochondrial ATP production (NMAP; 
C); and glycogen utilisation (D) during each exercise bout. ** P<0.01, *** P<0.001 versus 
pre-exercise value for same bout; † P<0.05, †† P<0.01, ††† P<0.001 versus corresponding 
bout one value.  Values are mean ± SE (n=21). 
 
Figure 3 Influence of L-carnitine supplementation on exercise performance following 24 
weeks HIT VO2max (A), Wattmax (B) and work output during training sessions (C) determined 
at baseline and following 12 and 24 weeks of HIT with twice daily beverages of either 80g 
carbohydrate (CON; black bars) or 80g carbohydrate + 1.5g L-carnitine (CARN; white bars). 
**P<0.01, ***P<0.001 main effect of HIT vs baseline. Values are mean ± SE (n=7 per 
group). 
 
Figure 4 Influence of L-carnitine supplementation on repeated bout exercise 
metabolism following 24 weeks HIT Post-exercise free carnitine (solid bars) and 
acetylcarnitine (dotted bars) concentrations (A) and PDC activation status after two 3 minute 
cycle ergometer exercise bouts at 100% Wattmax following 24 weeks of HIT with twice daily 
beverages of either 80g carbohydrate (CON; black bars) or 80g carbohydrate + 1.5g L-
carnitine (CARN; white bars). The contribution of ATP degradation (black bars), PCr 
degradation (white bars) and lactate accumulation (dotted bars) to total non-mitochondrial 
ATP production (NMAP; C); and glycogen utilisation (D) during each exercise bout 
following HIT and supplementation. * P<0.05 versus CON. Values are mean ± SE (n=7 per 
group). 
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Supporting Table 1 
 Skeletal muscle metabolite concentrations (mmol·kg dw-1) and PDC activation status (nmol 
acetyl-CoA·mg protein·min-1) before and immediately following two 3 minute exercise bouts 
at 100% Wattmax, at baseline and after 24 weeks of high-intensity exercise training and twice 
daily ingestion of either 80 g carbohydrate (CON; n=7) or 80 g carbohydrate + 1.5 g L-
carnitine-tartrate (CARN; n=7). * P<0.05, ** P<0.01 vs baseline; † P<0.05 vs CON. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supporting table 1 
  BOUT ONE  BOUT TWO 
  PRE  POST  PRE  POST 
  CON CARN  CON CARN  CON CARN  CON CARN 
0 
ATP 25.6 ± 1.3 24.9 ± 0.9  23.5 ± 1.1 22.1 ± 1.7  24.2 ± 2.0 21.7 ± 1.4  20.0 ± 1.8 19.7 ± 1.2 
PCr 72.3 ± 4.0 74.7 ± 3.4  55.4 ± 7.2 50.1 ± 7.7  74.1 ± 3.9 73.4 ± 5.1  25.8 ± 7.3 23.4 ± 3.6 
Lactate 4.5 ± 0.6 7.2 ± 1.7  39.0 ± 10.9 51.2 ± 20.7  15.8 ± 2.1 19.6 ± 7.3  91.3 ± 15.4 83.9 ± 8.2 
Glycogen 378 ± 28 413 ± 20  318 ± 21 347 ± 15  399 ± 23 375 ± 31  243 ± 13 264 ± 24 
Free carnitine 14.2 ± 0.7 16.9 ± 0.8  11.1 ± 1.1 11.7 ± 1.6  12.0 ± 0.8 13.6 ± 1.6  7.5 ± 1.3 8.4 ± 1.2 
Acetylcarnitine 2.8 ± 0.7 2.3 ± 0.9  5.7 ± 1.2 6.4 ± 1.6  5.0 ± 1.0 5.3 ± 2.0  9.0  ± 0.6 9.8 ± 1.1 
PDCa 3.6 ± 0.9  3.8 ± 0.7  4.8 ± 1.7 5.7 ± 1.5  2.7 ± 0.7 2.8 ± 0.4  7.6 ± 2.3 9.7 ± 1.2 
24 
ATP 23.6 ± 1.5 24.0 ± 1.0  25.0 ± 1.1 24.2 ± 1.6  23.6 ± 1.1 23.8 ± 1.1  22.8 ± 1.1 23.6 ± 1.6* 
PCr 73.9 ± 3.8 78.1 ± 3.2  65.5 ± 5.7 70.8 ± 5.3*  77.6 ± 1.9 78.5 ± 4.1  49.1 ± 7.2* 48.9 ± 9.2* 
Lactate 8.0 ± 2.4 6.7 ± 1.5  23.0 ± 7.3 16.7 ± 6.1*  23.0 ± 3.1 20.0 ± 4.5  50.2 ± 9.7* 53.6 ± 11.7* 
Glycogen 567 ± 33** 570 ± 46*  501 ± 32** 536 ± 40**  516 ± 48 532 ± 44*  462 ± 55** 479 ± 55** 
Free carnitine 13.5 ± 1.4 17.6 ± 1.6†  11.3 ± 0.7 16.4 ± 1.6*†  11.8 ± 0.8 16.5 ± 1.3†  10.5 ± 1.6 11.9 ± 1.9 
Acetylcarnitine 2.9 ± 0.7 2.8 ± 0.7  4.9 ± 1.2 4.0 ± 0.7  4.2 ± 0.6 3.9 ± 0.9  5.7 ± 0.9 7.7 ± 1.9 
PDCa 3.0 ± 0.7 3.8 ± 0.8  7.8 ± 2.5 3.7 ± 1.4  3.4 ± 1.4 3.3 ± 1.4  8.2 ± 2.3 7.6 ± 2.2 
